Annual Drug Patent Expirations for UKONIQ
Ukoniq is a drug marketed by Tg Theraps and is included in one NDA. There are seven patents protecting this drug.
This drug has fifty-six patent family members in thirty countries.
The generic ingredient in UKONIQ is umbralisib tosylate. Additional details are available on the umbralisib tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
